Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Cancer

Explore clinical trials studying Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

1,330 public trials 286 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Cancer trial results

Recruiting

Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

NCT07491445

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +13 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 49 locations
View Trial Details
Recruiting

CREO - Microwave Ablation Feasibility Study

NCT07817147

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +20 more
Locations
  • Banner MD Anderson Cancer Center and Gateway Hospital Gilbert, Arizona, United States
  • Cedars Sinai Los Angeles, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Mayo Clinic Rochester Rochester, Minnesota, United States
View Trial Details
Recruiting

Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach

NCT05764720

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Washington University, St. Louis St Louis, Missouri, United States
  • UH Cleveland Medical Center Cleveland, Ohio, United States
  • City of Hope Duarte, California, United States
View Trial Details
Recruiting

Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

NCT07621718

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +13 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Piedmont Healthcare Atlanta, Georgia, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View Trial Details
Recruiting

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

NCT06440005

Conditions
Advanced Cancer, Angiosarcoma, Breast Cancer, +46 more
Locations
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Florida Cancer Specialist Sarasota, Florida, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Sarah Cannon Research Center Nashville, Tennessee, United States
View Trial Details

Related conditions